TTI ellebeu,Inc plays an important role in supporting the development of healthcare technologies by spreading our proprietary drug delivery system (TCTTM), and conducts global activities for the purpose of making significant contribution to the betterment of the quality of life (QOL) of many patients who are suffering from various diseases.
 |
November 14, 2008 |
Transcu Ltd., TTI ellebeau's parent company, successfully completed Reverse Takeover ("RTO") with Eng Wah Organization Limited ("Eng Wah") today, and has been listed on the main board of Singapore Exchange ("Exchange"). |
|
April 1, 2008 |
On April 1, 2008, a director was additionally appointed (Decision made on March 31, 2008 by unanimous consent of sole shareholder in writing) and change in corporate organization (Decision of the Board of Directors on March 27, 2008) |
|
January 28, 2008 |
Resolutions of the General Meeting of Shareholders and the Board of Directors on January 25, 2008. |
|
December 17, 2007 |
Head office was moved to 4-8-8 Higashi-shinagawa,Shinagawa-ku,Tokyo. |
|
November 27, 2007 |
Conclusion of a License Agreement with Otsuka Pharmaceutical Co., Ltd. |
|
October 25, 2007 |
At the request of TRANSCU LTD.(Formerly known as Transcu Pte. Ltd.,"TRANSCU"), our Parent company, we are pleased to announce. |
|
September 1, 2007 |
Transcutaneous technologies,Inc started as TTI ellebeau,Inc. newly. |
|
May 23, 2007 |
Renewed NEWS. |
|
March 22, 2007 |
Renewed NEWS. |
|
January 30, 2007 |
Renewed NEWS. |
|
October 31, 2006 |
Re-launched our website. |
|
October 25, 2006 |
Announcement: Completion of clinial trials. |
| |
|
|
|
|
